Envista Posts Mixed Q2, Retained Earnings Up to $1.054B

TL;DR

**NVST is holding steady, but watch those capital adjustments; it's a grind, not a sprint.**

AI Summary

Envista Holdings Corp (NVST) reported a mixed financial performance for the second quarter ended June 27, 2025. Revenue for the quarter was not explicitly detailed in the provided excerpt, but the company's net income and other financial metrics indicate ongoing operational adjustments. The company's accumulated other comprehensive income decreased from -$47.586 million at December 31, 2024, to -$21.594 million at June 27, 2025, suggesting an improvement in certain non-owner changes in equity. Retained earnings increased from $1.047 billion at December 31, 2024, to $1.054 billion at June 27, 2025, reflecting profitability. The number of common shares outstanding remained stable at 169.5 million shares. Key business changes include adjustments to additional paid-in capital, which decreased from $2.049 billion at December 31, 2024, to $2.047 billion at June 27, 2025. Risks include fluctuations in accumulated other comprehensive income and managing treasury stock, which saw a slight increase from $1.157 billion to $1.158 billion. The strategic outlook appears focused on maintaining profitability and managing capital structure effectively.

Why It Matters

Envista's Q2 performance, particularly the increase in retained earnings to $1.054 billion, signals a stable financial foundation for investors, despite some capital adjustments. This stability is crucial in the competitive dental equipment and supplies market, where companies like Dentsply Sirona and Align Technology are constantly innovating. For employees, consistent profitability ensures job security and potential for growth. Customers can expect continued investment in product development and service quality, reinforcing Envista's market position. The broader market will watch how Envista leverages its capital structure to drive future growth and innovation in dental technology.

Risk Assessment

Risk Level: medium — The risk level is medium due to the fluctuations in accumulated other comprehensive income, which decreased from -$47.586 million to -$21.594 million, indicating volatility in non-owner equity changes. Additionally, the slight decrease in additional paid-in capital from $2.049 billion to $2.047 billion suggests ongoing capital management activities that could impact shareholder value if not effectively managed.

Analyst Insight

Investors should monitor Envista's future filings for detailed revenue figures and explanations for changes in accumulated other comprehensive income. A deeper dive into the drivers of these capital adjustments will provide clarity on the company's financial health and strategic direction.

Key Numbers

• $1.054B — Retained Earnings (Increased from $1.047 billion at December 31, 2024, to $1.054 billion at June 27, 2025, indicating profitability.)
• -$21.594M — Accumulated Other Comprehensive Income (Improved from -$47.586 million at December 31, 2024, to -$21.594 million at June 27, 2025, suggesting reduced negative non-owner equity changes.)
• $2.047B — Additional Paid-In Capital (Decreased from $2.049 billion at December 31, 2024, to $2.047 billion at June 27, 2025, reflecting capital adjustments.)
• $1.158B — Treasury Stock Common (Increased slightly from $1.157 billion at December 31, 2024, to $1.158 billion at June 27, 2025, indicating share repurchase activity or other treasury stock movements.)
• 169.5M — Common Shares Outstanding (Remained stable at 169.5 million shares from December 31, 2024, to June 27, 2025.)

Key Players & Entities

• Envista Holdings Corp (company) — filer of the 10-Q
• Dentsply Sirona (company) — competitor in the dental equipment market
• Align Technology (company) — competitor in the dental equipment market
• Bloomberg (company) — publisher of the analysis
• SEC (regulator) — regulator for financial filings
• 2025-06-27 (date) — end of the reporting period
• 2024-12-31 (date) — previous fiscal year-end
• 169.5 million (dollar_amount) — common shares outstanding

FAQ

Industry Context

Envista Holdings Corp operates in the Dental Equipment & Supplies industry (SIC 3843). This sector is characterized by innovation in dental technology, including digital imaging, CAD/CAM systems, and implantology. Key trends include the increasing adoption of digital dentistry solutions, a growing demand for aesthetic dental procedures, and an aging global population driving demand for dental care.

Regulatory Implications

As a medical device manufacturer, Envista is subject to stringent regulations from bodies like the FDA in the United States and similar agencies globally. Compliance with quality management systems (e.g., ISO 13485) and product safety standards is critical. Changes in healthcare policies or reimbursement rates could also impact demand for its products.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]
4. [object Object]

Key Dates

• 2025-06-27: End of Second Quarter 2025 — Reporting period for the 10-Q filing, providing updated financial position and performance.
• 2025-07-31: Filing Date of 10-Q — Indicates when the company officially submitted its quarterly financial report to the SEC.
• 2024-12-31: End of Fiscal Year 2024 — Baseline for comparison of year-to-year changes in financial statements, particularly equity accounts.
• 2024-06-28: End of Second Quarter 2024 — Previous year's comparable period for analyzing year-over-year trends in financial performance and position.

Glossary

Accumulated Other Comprehensive Income

Represents unrealized gains and losses that have not yet been recognized in net income. This can include items like foreign currency translation adjustments or changes in the value of certain investments. (A decrease in its negative value from -$47.586 million to -$21.594 million indicates an improvement in these non-owner equity changes.)

Retained Earnings

The cumulative amount of net income that a company has retained over time, after paying out dividends. (An increase from $1.047 billion to $1.054 billion signifies that the company has been profitable and reinvesting earnings back into the business.)

Additional Paid-In Capital

The amount of capital a company receives from shareholders in exchange for stock, above the stock's par value. (A slight decrease from $2.049 billion to $2.047 billion suggests minor adjustments in equity transactions, such as stock-based compensation or share repurchases.)

Treasury Stock Common

Represents shares of the company's own stock that it has repurchased from the open market. These shares are no longer outstanding. (A slight increase from $1.157 billion to $1.158 billion indicates ongoing share repurchase activity or other transactions involving treasury stock.)

Common Shares Outstanding

The total number of shares of a company's stock that are currently held by all its shareholders, including shares held by institutional investors and insiders. (Stability at 169.5 million shares suggests no significant issuance or repurchase of common stock during the period.)

Year-Over-Year Comparison

The provided data focuses on equity accounts and does not include comparative income statement or cash flow figures from the prior year's 10-Q. However, the changes in equity accounts like retained earnings (increased) and accumulated other comprehensive income (improved) suggest a potentially positive operational performance compared to the prior period, despite unspecified 'operational adjustments'.

From the Filing

0001757073-25-000044.txt : 20250731 0001757073-25-000044.hdr.sgml : 20250731 20250731161951 ACCESSION NUMBER: 0001757073-25-000044 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 89 CONFORMED PERIOD OF REPORT: 20250627 FILED AS OF DATE: 20250731 DATE AS OF CHANGE: 20250731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Envista Holdings Corp CENTRAL INDEX KEY: 0001757073 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 832206728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39054 FILM NUMBER: 251171950 BUSINESS ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 BUSINESS PHONE: 714-817-5418 MAIL ADDRESS: STREET 1: 200 S. KRAEMER BLVD., BLDG. E CITY: BREA STATE: CA ZIP: 92821 FORMER COMPANY: FORMER CONFORMED NAME: DH Dental Holding Corp. DATE OF NAME CHANGE: 20181025 10-Q 1 nvst-20250627.htm 10-Q nvst-20250627 false 2025 Q2 12/31 0001757073 0.0475862 0.0215942 xbrli:shares iso4217:USD iso4217:USD xbrli:shares nvst:segment iso4217:EUR xbrli:pure nvst:tradingDay 0001757073 2025-01-01 2025-06-27 0001757073 2025-07-25 0001757073 2025-06-27 0001757073 2024-12-31 0001757073 2025-03-29 2025-06-27 0001757073 2024-03-30 2024-06-28 0001757073 2024-01-01 2024-06-28 0001757073 us-gaap:CommonStockMember 2024-12-31 0001757073 us-gaap:TreasuryStockCommonMember 2024-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001757073 us-gaap:RetainedEarningsMember 2024-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-28 0001757073 2025-01-01 2025-03-28 0001757073 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-28 0001757073 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-28 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-28 0001757073 us-gaap:CommonStockMember 2025-03-28 0001757073 us-gaap:TreasuryStockCommonMember 2025-03-28 0001757073 us-gaap:AdditionalPaidInCapitalMember 2025-03-28 0001757073 us-gaap:RetainedEarningsMember 2025-03-28 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-28 0001757073 2025-03-28 0001757073 us-gaap:AdditionalPaidInCapitalMember 2025-03-29 2025-06-27 0001757073 us-gaap:TreasuryStockCommonMember 2025-03-29 2025-06-27 0001757073 us-gaap:RetainedEarningsMember 2025-03-29 2025-06-27 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-29 2025-06-27 0001757073 us-gaap:CommonStockMember 2025-06-27 0001757073 us-gaap:TreasuryStockCommonMember 2025-06-27 0001757073 us-gaap:AdditionalPaidInCapitalMember 2025-06-27 0001757073 us-gaap:RetainedEarningsMember 2025-06-27 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-27 0001757073 us-gaap:CommonStockMember 2023-12-31 0001757073 us-gaap:TreasuryStockCommonMember 2023-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001757073 us-gaap:RetainedEarningsMember 2023-12-31 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001757073 2023-12-31 0001757073 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-29 0001757073 2024-01-01 2024-03-29 0001757073 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-29 0001757073 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-29 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-29 0001757073 us-gaap:CommonStockMember 2024-03-29 0001757073 us-gaap:TreasuryStockCommonMember 2024-03-29 0001757073 us-gaap:AdditionalPaidInCapitalMember 2024-03-29 0001757073 us-gaap:RetainedEarningsMember 2024-03-29 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-29 0001757073 2024-03-29 0001757073 us-gaap:AdditionalPaidInCapitalMember 2024-03-30 2024-06-28 0001757073 us-gaap:RetainedEarningsMember 2024-03-30 2024-06-28 0001757073 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-